Annual Accounts Payable
$2.74 M
-$2.71 M-49.74%
31 December 2023
Summary:
Century Therapeutics annual accounts payable is currently $2.74 million, with the most recent change of -$2.71 million (-49.74%) on 31 December 2023. During the last 3 years, it has fallen by -$5.34 million (-66.09%). IPSC annual accounts payable is now -66.09% below its all-time high of $8.08 million, reached on 31 December 2020.IPSC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.60 M
-$760.00 K-22.63%
30 September 2024
Summary:
Century Therapeutics quarterly accounts payable is currently $2.60 million, with the most recent change of -$760.00 thousand (-22.63%) on 30 September 2024. Over the past year, it has dropped by -$3.33 million (-56.17%). IPSC quarterly accounts payable is now -80.65% below its all-time high of $13.43 million, reached on 30 June 2021.IPSC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPSC Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.7% | -56.2% |
| 3 y3 years | -66.1% | -77.7% |
| 5 y5 years | - | - |
IPSC Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -66.1% | at low | -77.7% | at low |
| 5 y | 5 years | -66.1% | +77.1% | -80.7% | at low |
| alltime | all time | -66.1% | +77.1% | -80.7% | at low |
Century Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.60 M(-22.6%) |
| June 2024 | - | $3.36 M(-2.2%) |
| Mar 2024 | - | $3.43 M(+25.2%) |
| Dec 2023 | $2.74 M(-49.7%) | $2.74 M(-53.8%) |
| Sept 2023 | - | $5.93 M(+63.5%) |
| June 2023 | - | $3.63 M(+4.3%) |
| Mar 2023 | - | $3.48 M(-36.3%) |
| Dec 2022 | $5.45 M | $5.45 M(-4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $5.68 M(+40.4%) |
| June 2022 | - | $4.05 M(-59.1%) |
| Mar 2022 | - | $9.89 M(+30.2%) |
| Dec 2021 | $7.60 M(-6.0%) | $7.60 M(-34.8%) |
| Sept 2021 | - | $11.64 M(-13.3%) |
| June 2021 | - | $13.43 M(+52.3%) |
| Mar 2021 | - | $8.82 M(+9.1%) |
| Dec 2020 | $8.08 M(+422.1%) | $8.08 M |
| Dec 2019 | $1.55 M | - |
FAQ
- What is Century Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Century Therapeutics?
- What is Century Therapeutics annual accounts payable year-on-year change?
- What is Century Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Century Therapeutics?
- What is Century Therapeutics quarterly accounts payable year-on-year change?
What is Century Therapeutics annual accounts payable?
The current annual accounts payable of IPSC is $2.74 M
What is the all time high annual accounts payable for Century Therapeutics?
Century Therapeutics all-time high annual accounts payable is $8.08 M
What is Century Therapeutics annual accounts payable year-on-year change?
Over the past year, IPSC annual accounts payable has changed by -$2.71 M (-49.74%)
What is Century Therapeutics quarterly accounts payable?
The current quarterly accounts payable of IPSC is $2.60 M
What is the all time high quarterly accounts payable for Century Therapeutics?
Century Therapeutics all-time high quarterly accounts payable is $13.43 M
What is Century Therapeutics quarterly accounts payable year-on-year change?
Over the past year, IPSC quarterly accounts payable has changed by -$3.33 M (-56.17%)